Safety Alerts & Recalls
What does this mean?
This recall for Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation from AstraZeneca Pharmaceuticals LP was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation and are concerned, you should speak to your doctor or pharmacist.
AstraZeneca Pharmaceuticals LP Recalls Select Lots of Tudorza Pressair, 400 mcg per actuation
AstraZeneca Pharmaceuticals LP is recalling select lots of Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation. The following lot numbers are being recalled because the inhaler counter in these lots may be set to a number other than 60: Lot # 1144394, Expiry: 04/2018; Lot # 1145539, Expiry: 04/2018; Lot # 1145868, Expiry: 05/2018
Tudorza Pressair contains the active ingredient aclindinium bromide and is commonly used in the treatment of COPD. This recall alert only applies to the select lots of Tudorza Pressair, 400 mcg per actuation. No other Tudorza products were involved in this recall.
To search for and view the FDA notice about this recall, please visit: more information here